IL18 and cryopyrin-associated periodic syndrome: In fact, LPS-stimulated human blood-derived macrophages and monocytes from patients with cryopyrin-associated periodic syndrome (CAPS) treated with OLT1177 presented a decreased level of IL-1β and IL-18.